UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 8, 2016

 

 

IMS Health Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36381   27-1335689

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

83 Wooster Heights Road

Danbury, CT 06810

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (203) 448-4600

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On April 8, 2016, IMS Health Holdings, Inc. held its 2016 Annual Meeting of Stockholders. At the meeting, stockholders voted on the following items:

Proposal No. 1:  The following nominees were elected by majority vote to serve on the Board of Directors:

 

     For      Against      Abstain      Broker Non-Vote  

John G. Danhakl

     256,329,619         60,027,889         62,277         4,633,492   

Karen L. Katen

     307,172,560         9,245,818         1,407         4,633,492   

Bryan M. Taylor

     257,168,799         59,188,809         62,177         4,633,492   

Proposal No. 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2016 was ratified.

 

For

  

Against

  

Abstain

  

Broker Non-Vote

318,884,253

   2,152,428    16,596    N/A

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  IMS Health Holdings, Inc.
Date: April 8, 2016     By:  

/s/ Ronald E. Bruehlman

      Name:   Ronald E. Bruehlman
      Title:   Senior Vice President and Chief Financial Officer
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more IMS HEALTH HOLDINGS, INC. Charts.